HIF Bio v. Yung Shin Pharmaceuticals

NOTE: This order is nonprecedential. United States Court of Appeals for the Federal Circuit __________________________ HIF BIO, INC. AND BIZBIOTECH CO., LTD., Plaintiffs-Appellees, v. YUNG SHIN PHARMACEUTICALS INDUSTRIAL CO., LTD. (DOING BUSINESS AS YUNG SHIN PHARMACEUTICALS AND YUNG SHIN PHARM. IND. CO. LTD.), YUNG ZIP CHEMICAL CO., LTD., FANG-YU LEE, AND CHE-MING TENG, Defendants, and CARLSBAD TECHNOLOGY, INC., Defendant-Appellant, and FISH AND RICHARDSON P.C., AND Y. ROCKY TSAO, Defendants. __________________________ 2006-1522 __________________________ HIF BIO v. YUNG SHIN PHARMA 2 Appeals from the United States District Court for the Central District of California in case no. 05-CV-07976, Judge Dean D. Pregerson. ON PETITION FOR REHEARING __________________________ Before MICHEL, Chief Judge, * GAJARSA, Circuit Judge, and HOLDERMAN, Chief District Judge. ** ORDER Defendant-Appellant Carlsbad Technology, Inc. filed a combined petition for panel rehearing and rehearing en banc. The petition for panel rehearing was considered by the panel that heard the appeal. The panel grants the petition for panel rehearing for the limited purpose of amending page 16, lines 12-18 of the issued opinion. Accordingly, IT IS ORDERED THAT: (1) The petition for panel rehearing is granted for the limited purpose of amending the following language on page 16, lines 12-18 of the issued opinion: Because the second and fourth causes of action arise under § 1338(a), the district court abused its discretion in remanding those causes of action the First Amended Complaint to state court. See Hunter Douglas, Inc., 153 F.3d at 1328; Baker, 387 F.3d at 656-57. However, on remand the district court should dismiss both the second and fourth causes of action under Rule 12(b)(6) because * Paul R. Michel retired from the position of Chief Judge on May 31, 2010. ** The Honorable James F. Holderman, Chief Judge, United States District Court for the Northern District of Illinois, sitting by designation. 3 HIF BIO v. YUNG SHIN PHARMA plaintiffs have failed to state a claim upon which relief can be granted. Pursuant to 28 U.S.C. § 1367(c), the district court has discretion to decide on remand whether to exercise supplemental jurisdiction over the remaining causes of action. Additionally, because the remaining state law claims do not arise under federal law, the district should remand them to California state court. (2) The petition for panel rehearing is otherwise denied. FOR THE COURT June 14, 2010 /s/ Jan Horbaly —————————— —————————— Date Jan Horbaly Clerk cc: Bub-Joo S. Lee, Esq. Glenn W. Rhodes, Esq.